Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-194,078
Closed -$1.19M 1026
2022
Q3
$1.19M Sell
194,078
-18,718
-9% -$142K 0.01% 413
2022
Q2
$1.04M Buy
212,796
+20,140
+10% +$176K 0.01% 467
2022
Q1
$2.44M Sell
192,656
-65,375
-25% -$720K 0.03% 180
2021
Q4
$3.17M Buy
258,031
+5,446
+2% +$96.2K 0.04% 190
2021
Q3
$4.62M Buy
252,585
+34,572
+16% +$382K 0.04% 179
2021
Q2
$2.44M Buy
218,013
+51,857
+31% +$817K 0.02% 268
2021
Q1
$4.07M Buy
+166,156
New +$1.86M 0.04% 187

Other funds holding AMTX

ALPS Advisors's AMTX Position: Q4 2022 in Review

ALPS Advisors sold out of Aemetis (AMTX) in Q4 2022, closing a stake of 194,078 shares — an estimated $1.19M sold.

ALPS Advisors first reported a position in AMTX in Q1 2021 and held it in 7 quarters. The position peaked at $4.62M in Q3 2021. 91 funds tracked by Wall St. Rank hold AMTX as of Q4 2022.

  • ALPS Advisors reported no remaining Aemetis position as of Q4 2022 after selling out during the quarter.
  • ALPS Advisors sold 194,078 Aemetis shares in Q4 2022, an estimated $1.19M.
  • ALPS Advisors first reported a position in Aemetis in Q1 2021 and held it in 7 quarters.
  • ALPS Advisors's Aemetis position peaked at $4.62M in Q3 2021.
  • 91 funds tracked by Wall St. Rank held Aemetis as of Q4 2022.

Based on ALPS Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.